Appetite suppression through dopamine modulation Central appetite control: Tesofensine acts on hypothalamus Affects arcuate nucleus (appetite center) Different pathway from GLP-1 receptors Direct neurotransmitter modulation Rapid onset (hours not days) Dopamine's role in eating: Mediates food reward (hedonic eating) High-dopamine = reduced food seeking Decreases obsessive food thoughts Reduces binge eating tendencies Similar to ADHD medication effects Subjective appetite changes reported: Reduced hunger (moderate, not as strong as semaglutide ) Less food preoccupation Earlier satiety (smaller portions satisfying) Reduced cravings especially for high-calorie foods More mental focus on non-food activities Appetite suppression comparison: Why dopamine approach different: Addresses psychological/behavioral eating Reduces food as reward behavior Helps with emotional eating Less GI side effects than GLP-1s But creates stimulant-like dependency risk Clinical trial results and efficacy Evidence from human studies
If a person has a liver disorder, for example liver disease, then the liver is unable to store vitamin B12 and this can lead to a B12 deficiency
A handful of peptides will keep your blood sugar more stable, making it even easier to stick to your goals
By enhancing satiety and reducing appetite, patients may experience a decrease in overall caloric intake
It's currently labeled as a category 2 substance, meaning that the FDA has identified an ingredient as having a possible safety risk and it cannot be used in compounded medications
Popular Peptides for Hormone Optimization CJC-1295 + Ipamorelin: The most widely prescribed GH-releasing peptide combination available through peptide therapy protocols
